ArticleCancers2022

Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis.

Francesco Del Giudice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.